Thr126
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr126  -  UNG (human)

Site Information
AEERKHytVyPPPHQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 453425

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , phospho-antibody ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
UV ( 2 )

References 

1

Possemato A (2008) CST Curation Set: 3661; Year: 2008; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS:pSXXXpS
Curated Info

2

Lu X, et al. (2004) The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell 15, 621-34
15327777   Curated Info